Medicago, Inc. Granted Patent for Influenza Virus-Like Particles in Plants
6/17/2013 10:53:00 AM
More...
|
Medicago, Inc. Receives Authorization From Health Canada and Commences Phase II Clinical Trial for an H5N1 Vaccine
6/11/2013 8:48:57 AM
More...
|
Medicago, Inc. is First in the World to Report Positive Interim Results for Its H7N9 Pre-Clinical Trial
6/6/2013 9:53:26 AM
More...
|
Medicago, Inc. Announces 2013 First Quarter Financial Results
5/10/2013 7:11:10 AM
More...
|
Medicago, Inc. Successfully Produces VLP Vaccine Candidate for H7N9 Virus Responsible for Recent Influenza Outbreak in China
5/8/2013 10:24:07 AM
More...
|
Medicago, Inc. Announces a $3.5 Million Private Placement
4/23/2013 10:37:16 AM
More...
|
Infectious Disease Research Institute (IDRI) and Medicago, Inc. Report Positive Results for Phase I Clinical Trial for an H5N1 Vaccine
4/18/2013 9:23:50 AM
More...
|
Infectious Disease Research Institute (IDRI) and Medicago, Inc. to Present Data at the World Vaccine Congress
4/9/2013 6:48:19 AM
More...
|
Medicago, Inc. Announces 2012 Fourth Quarter and Year-End Financial Results
3/29/2013 6:37:59 AM
More...
|
Medicago, Inc. Invited to Present at Upcoming U.S. Investor Conferences
2/26/2013 6:23:18 AM
More...
|
|